Suven Life Sciences Limited

Healthcare · Healthcare Services

NSE: SUVEN BSE: 530239

₹320.20

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #19 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Apollo Hospitals Enterprise Limited	117,407	74.7	20.1%	9.7%	—	73	0	27
Max Healthcare Institute Limited	90,492	126.0	13.4%	-16.5%	0.22%	77	0	26
Fortis Healthcare Limited	58,132	257.5	10.5%	-22.2%	0.13%	49	26	6
Global Health Limited	36,701	76.2	13.9%	4.6%	0.04%	74	0	30
Narayana Hrudayalaya Ltd.	36,609	64.4	17.8%	3.5%	0.25%	66	0	29
Aster DM Quality Care Limited	36,121	207.5	8.8%	10.5%	0.43%	53	0	26
Dr. Lal Path Labs Ltd.	33,310	38.7	20.1%	-37.3%	0.98%	82	0	88
Krishna Institute of Medical Sciences Limited	31,349	111.2	9.5%	8.5%	—	47	0	29
Suven Life Sciences Limited (this stock)	8,453	—	-46.7%	54.6%	—	20	0	29

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹8,451 Cr

EV / EBITDA

Data unavailable.

EV / Sales

958.79x

Market cap / Sales

959.05x

Earnings yield

Data unavailable.

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 11 Cr, up 351.5% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs -16 Cr, up 9.1% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	4	-16	-16	₹-0.6100
March 31, 2026	2	-11	-11	₹-0.5000
Dec. 31, 2025	3	-13	-13	₹-0.6000
Sept. 30, 2025	1	-15	-15	₹-0.7000
June 30, 2025	2	-15	-15	₹-0.6800
March 31, 2025	1	-15	-15	₹-0.6900
Dec. 31, 2024	2	-13	-13	₹-0.6100
Sept. 30, 2024	3	-11	-11	₹-0.5100
June 30, 2024	1	-8	-8	₹-0.3500
March 31, 2024	2	-4	-3	₹-0.1400
Dec. 31, 2023	2	-5	-5	₹-0.2200
Sept. 30, 2023	3	3	3	₹0.1300
June 30, 2023	4	-3	-3	₹-0.1300

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	11	8	6	5	2	3	3	7	5	7	9	8	9
Operating revenue	4	2	3	1	2	1	2	3	1	2	2	3	4
Other income	8	7	3	4	1	1	2	4	4	4	6	5	6
Operating expenses	25	18	18	19	16	16	15	16	11	9	12	11	11
Operating profit	-21	-16	-15	-18	-14	-15	-13	-14	-10	-7	-9	-8	-7
Operating profit margin	-589.2%	-1066.1%	-530.1%	-1948.4%	-749.8%	-1016.7%	-826.1%	-530.0%	-1002.7%	-288.0%	-375.3%	-263.9%	-179.0%
Depreciation	2	2	1	1	1	1	2	1	1	2	2	2	2
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	7	—
Profit before tax	-16	-11	-13	-15	-15	-15	-13	-11	-8	-4	-5	3	-3
Tax	—	—	—	—	—	—	—	—	—	-1	—	—	—
Net profit	-16	-11	-13	-15	-15	-15	-13	-11	-8	-3	-5	3	-3
EPS	-0.61	-0.50	-0.60	-0.70	-0.68	-0.69	-0.61	-0.51	-0.35	-0.14	-0.22	0.13	-0.13
Net profit (TTM)	-56	-55	-59	-59	-54	-47	-35	-27	-13	-8	-7	-9	-21
EPS (TTM)	-2.41	-2.48	-2.67	-2.68	-2.49	-2.16	-1.61	-1.22	-0.58	-0.36	-0.27	-0.40	-1.14

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	7	-55	-55
March 31, 2025	7	-47	-47
March 31, 2024	12	-9	-8
March 31, 2023	14	-20	-20

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	-1.5%	-0.2%	21^†	17^†	33^†	22^†	17^†	21^†	502^†	688^†	649^†	566^†
Operating revenue	-19.3%	-12.0%	7	7	12	14	12^†	13^†	485^†	664^†	625^†	544^†
Other income	—	—	14^†	11^†	21^†	8^†	5^†	8^†	17^†	24^†	23^†	21^†
Operating expenses	—	—	70^†	59^†	43^†	41^†	48^†	44^†	296^†	440^†	392^†	375^†
Operating profit	—	—	-63^†	-52^†	-31^†	-28^†	-37^†	-30^†	189^†	224^†	233^†	169^†
Operating profit margin	—	—	-885.5%^†	-780.3%^†	-264.6%^†	-204.9%^†	-309.4%^†	-226.1%^†	39.0%^†	33.7%^†	37.3%^†	31.1%^†
Depreciation	—	—	6^†	6^†	7^†	7^†	4^†	4^†	13^†	22^†	21^†	21^†
Interest	—	—	0^†	0^†	0^†	0^†	1^†	1^†	3^†	4^†	5^†	6^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	7^†	6^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	—	—	-55	-47	-9	-20	-36^†	-28^†	190^†	222^†	230^†	159^†
Tax	—	—	—	—	—	—	—	-5^†	68^†	72^†	72^†	36^†
Net profit	—	—	-55	-47	-8	-20	-36^†	-23^†	122^†	150^†	158^†	123^†
EPS	—	—	-2.48^†	-2.16^†	-0.36^†	—	-2.85^†	-1.78^†	9.62^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	-885.5%^†	-780.3%^†	-264.6%^†	-204.9%^†	-309.4%^†	-226.1%^†	39.0%^†	33.7%^†	37.3%^†	31.1%^†
EBIT margin	-768.9%^†	-706.6%^†	-75.7%^†	-146.5%^†	-301.6%^†	-200.9%^†	39.9%^†	34.0%^†	37.6%^†	30.3%^†
PBT margin	-771.1%	-707.3%	-77.1%	-148.7%	-306.1%^†	-207.4%^†	39.2%^†	33.4%^†	36.8%^†	29.3%^†
Net margin	-771.1%	-707.3%	-68.5%	-148.7%	-306.1%^†	-167.9%^†	25.3%^†	22.6%^†	25.3%^†	22.7%^†
Interest coverage	-346.67x^†	-1009.30x^†	-55.89x^†	-68.62x^†	-67.37x^†	-30.72x^†	55.42x^†	59.96x^†	50.94x^†	29.12x^†
Dividend payout	—	—	—	—	—	—	0.0%^†	—	—	—
Earnings retention	—	—	—	—	—	—	100.0%^†	—	—	—
Current ratio	144.20x	7.52x	—	—	—	—	—	—	—	—
Quick ratio	144.18x	7.49x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	-3.6%	-5.9%	—	—	—	—	—	—	—	—
Return on assets	-3.6%	-5.8%	—	—	—	—	—	—	—	—
Return on capital employed	-3.6%^†	-5.9%^†	—	—	—	—	—	—	—	—
Asset turnover	0.00x	0.01x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	-70	-686	757	5	-75
March 31, 2025	-47	44	-1	37	-85
March 31, 2024	12	-34	-1	-2	15
March 31, 2023	-115	-257	396	3	-118
March 31, 2022	-37	-107	146	20	-56

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	1,531	1,503	1,477	0	0	541	4	2	56	0
March 31, 2025	809	800	778	0	0	58	8	0	59	0
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.